X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs AJANTA PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA AJANTA PHARMA FULFORD INDIA/
AJANTA PHARMA
 
P/E (TTM) x 398.8 28.5 1,399.9% View Chart
P/BV x 6.2 11.7 52.9% View Chart
Dividend Yield % 0.1 0.5 16.6%  

Financials

 FULFORD INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
AJANTA PHARMA
Mar-16
FULFORD INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs9421,720 54.8%   
Low Rs4501,103 40.8%   
Sales per share (Unadj.) Rs691.4194.6 355.3%  
Earnings per share (Unadj.) Rs11.545.2 25.3%  
Cash flow per share (Unadj.) Rs15.450.3 30.5%  
Dividends per share (Unadj.) Rs2.008.00 25.0%  
Dividend yield (eoy) %0.30.6 50.7%  
Book value per share (Unadj.) Rs380.0132.0 287.8%  
Shares outstanding (eoy) m3.9088.77 4.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.07.3 13.9%   
Avg P/E ratio x60.731.2 194.5%  
P/CF ratio (eoy) x45.328.1 161.5%  
Price / Book Value ratio x1.810.7 17.1%  
Dividend payout %17.417.7 98.6%   
Avg Mkt Cap Rs m2,714125,299 2.2%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5052,570 19.7%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69617,275 15.6%  
Other income Rs m125166 75.4%   
Total revenues Rs m2,82217,442 16.2%   
Gross profit Rs m-465,807 -0.8%  
Depreciation Rs m15451 3.4%   
Interest Rs m1049 19.4%   
Profit before tax Rs m545,474 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,460 0.7%   
Profit after tax Rs m454,014 1.1%  
Gross profit margin %-1.733.6 -5.1%  
Effective tax rate %17.726.7 66.3%   
Net profit margin %1.723.2 7.1%  
BALANCE SHEET DATA
Current assets Rs m1,7387,639 22.8%   
Current liabilities Rs m5452,715 20.1%   
Net working cap to sales %44.328.5 155.3%  
Current ratio x3.22.8 113.4%  
Inventory Days Days4843 112.1%  
Debtors Days Days479 5.5%  
Net fixed assets Rs m126,914 0.2%   
Share capital Rs m39177 22.0%   
"Free" reserves Rs m1,44311,442 12.6%   
Net worth Rs m1,48211,721 12.6%   
Long term debt Rs m0149 0.0%   
Total assets Rs m2,07714,814 14.0%  
Interest coverage x6.7112.9 5.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.31.2 111.3%   
Return on assets %2.627.4 9.5%  
Return on equity %3.034.2 8.8%  
Return on capital %4.346.5 9.3%  
Exports to sales %055.1 0.0%   
Imports to sales %24.56.0 407.1%   
Exports (fob) Rs mNA9,527 0.0%   
Imports (cif) Rs m6591,038 63.5%   
Fx inflow Rs m1710,422 0.2%   
Fx outflow Rs m6731,678 40.1%   
Net fx Rs m-6568,744 -7.5%   
CASH FLOW
From Operations Rs m903,264 2.8%  
From Investments Rs m105-2,093 -5.0%  
From Financial Activity Rs m-14-1,186 1.2%  
Net Cashflow Rs m181-15 -1,219.6%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 1.6 245.2%  
FIIs % 0.1 7.6 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.0 124.7%  
Shareholders   4,783 20,968 22.8%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - IPCA LABS COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS